SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Davide Francomano, Emanuela A. Greco, Andrea Lenzi, Antonio Aversa, CAG Repeat Testing of Androgen Receptor Polymorphism: Is This Necessary for the Best Clinical Management of Hypogonadism?, The Journal of Sexual Medicine, 2013, 10, 10
  2. 2
    Tudor Borza, Ramdev Konijeti, Adam S. Kibel, Early Detection, PSA Screening, and Management of Overdiagnosis, Hematology/Oncology Clinics of North America, 2013, 27, 6, 1091

    CrossRef

  3. 3
    Jeannette T. Bensen, Zongli Xu, Gary J. Smith, James L. Mohler, Elizabeth T.H. Fontham, Jack A. Taylor, Genetic polymorphism and prostate cancer aggressiveness: A case-only study of 1,536 GWAS and candidate SNPs in African-Americans and European-Americans, The Prostate, 2013, 73, 1
  4. 4
    S Madjunkova, A Eftimov, V Georgiev, D Petrovski, A Dimovski, D Plaseska-Karanfilska, Cag Repeat Number in the Androgen Receptor Gene and Prostate Cancer, Balkan Journal of Medical Genetics, 2012, 15, 1

    CrossRef

  5. 5
    Monika Kmeťová Sivoňová, Dušan Dobrota, Róbert Dušenka, Iveta Waczulíková, Peter Slezák, Tatiana Matáková, Silvia Mahmoodová, Dušan Mištuna, Ján Kliment, Effect of CYP17 and PSA gene polymorphisms on prostate cancer risk and circulating PSA levels in the Slovak population, Molecular Biology Reports, 2012, 39, 8, 7871

    CrossRef

  6. 6
    Xiaoye Zhu, Peter C. Albertsen, Gerald L. Andriole, Monique J. Roobol, Fritz H. Schröder, Andrew J. Vickers, Risk-Based Prostate Cancer Screening, European Urology, 2012, 61, 4, 652

    CrossRef

  7. 7
    R. Kumar, H. Atamna, M.N. Zakharov, S. Bhasin, S.H. Khan, R. Jasuja, Role of the androgen receptor CAG repeat polymorphism in prostate cancer, and spinal and bulbar muscular atrophy, Life Sciences, 2011, 88, 13-14, 565

    CrossRef

  8. 8
    Yen-Ching Chen, John H. Page, Rong Chen, Edward Giovannucci, Family history of prostate and breast cancer and the risk of prostate cancer in the PSA era, The Prostate, 2008, 68, 14
  9. 9
    Jiyoung Ahn, Roxana Moslehi, Stephanie J. Weinstein, Kirk Snyder, Jarmo Virtamo, Demetrius Albanes, Family history of prostate cancer and prostate cancer risk in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study, International Journal of Cancer, 2008, 123, 5
  10. 10
    S. L. McFall, J. Ureda, T. L. Byrd, A. Valdes, P. Morales, D. B. Scott, D. Williams, J. Calderon-Mora, M. E. Casillas, E. C. Y. Chan, What is needed for informed decisions about prostate cancer screening: perspectives of African-American and Hispanic men, Health Education Research, 2008, 24, 2, 280

    CrossRef

  11. 11
    David M. Latini, Eric P. Elkin, Matthew R. Cooperberg, Natalia Sadetsky, Janeen DuChane, Peter R. Carroll, Differences in clinical characteristics and disease-free survival for Latino, African American, and non-Latino white men with localized prostate cancer, Cancer, 2006, 106, 4
  12. 12
    Stephanie L. McFall, Robert M. Hamm, Robert J. Volk, Exploring beliefs about prostate cancer and early detection in men and women of three ethnic groups, Patient Education and Counseling, 2006, 61, 1, 109

    CrossRef

  13. 13
    Cynthia G. Norris, Stephanie McFall, Lifestyle and Clinical Health Behaviors and PSA Tests, American Journal of Health Education, 2006, 37, 5, 289

    CrossRef

  14. 14
    Elizabeth Kudadjie-Gyamfi, Nathan S. Consedine, Carol Magai, On the importance of being ethnic: Coping with the threat of prostate cancer in relation to prostate cancer screening., Cultural Diversity and Ethnic Minority Psychology, 2006, 12, 3, 509

    CrossRef

  15. 15
    Morgan Rouprêt, Gaëlle Fromont, Marc-Olivier Bitker, Bernard Gattegno, Guy Vallancien, Olivier Cussenot, Outcome after radical prostatectomy in young men with or without a family history of prostate cancer, Urology, 2006, 67, 5, 1028

    CrossRef

  16. 16
    Sally P. Weinrich, Prostate cancer screening in high-risk men, Cancer, 2006, 106, 4
  17. 17
    Deepa Pookot, Long-Cheng Li, Z. Laura Tabatabai, Yuichiro Tanaka, Kirsten L. Greene, Rajvir Dahiya, The E-Cadherin −160 C/A Polymorphism and Prostate Cancer Risk in White and Black American Men, The Journal of Urology, 2006, 176, 2, 793

    CrossRef

  18. 18
    Jane C. Schroeder, Jeannette T. Bensen, L. Joseph Su, Merle Mishel, Anastasia Ivanova, Gary J. Smith, Paul A. Godley, Elizabeth T. H. Fontham, James L. Mohler, The North Carolina–Louisiana Prostate Cancer Project (PCaP): Methods and design of a multidisciplinary population-based cohort study of racial differences in prostate cancer outcomes, The Prostate, 2006, 66, 11
  19. 19
    Christian Twiss, Denisa Slova, Herbert Lepor, Outcomes for men younger than 50 years undergoing radical prostatectomy, Urology, 2005, 66, 1, 141

    CrossRef

  20. 20
    Long-Cheng Li, Steven T. Okino, Rajvir Dahiya, DNA methylation in prostate cancer, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2004, 1704, 2, 87

    CrossRef

  21. 21
    David G. Bostwick, Harry B. Burke, Daniel Djakiew, Susan Euling, Shuk-mei Ho, Joseph Landolph, Howard Morrison, Babasaheb Sonawane, Tiffany Shifflett, David J. Waters, Barry Timms, Human prostate cancer risk factors, Cancer, 2004, 101, S10
  22. 22
    Jeffrey B Marotte, Michelle K Ferrari, John E McNeal, James D Brooks, Joseph C Presti, Time trends in pathologic features of radical prostatectomy—impact of family history, Urologic Oncology: Seminars and Original Investigations, 2004, 22, 3, 169

    CrossRef

  23. 23
    Rinaa S. Punglia, Anthony V. D'Amico, William J. Catalona, Kimberly A. Roehl, Karen M. Kuntz, Effect of Verification Bias on Screening for Prostate Cancer by Measurement of Prostate-Specific Antigen, New England Journal of Medicine, 2003, 349, 4, 335

    CrossRef